Company · MDLN
Medline Inc.
Nasdaq's symbol directory lists MDLN on Nasdaq as “Medline Inc. - Class A common stock”.
In the 12 months to Nov 8, 2026: insiders sold on 10 occasions ($1.2B); 5 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 35
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- GIC Private Ltd sold $1.2B
- Golwas Douglas P, Chief Commercial Officer sold $3.7M
Every trade (10)
- SELLGIC Private Ltd sold $274.8M
- SELLGIC Private Ltd sold $325.0M
- SELLGIC Private Ltd sold $60.4M
- SELLGIC Private Ltd sold $336.2M
- SELLGIC Private Ltd sold $3.6M
- SELLGIC Private Ltd sold $53.7M
- SELLGIC Private Ltd sold $21.0M
- SELLGIC Private Ltd sold $9.6M
- SELLGIC Private Ltd sold $70.4M
- SELLGolwas Douglas P, Chief Commercial Officer sold $3.7M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- GIC Private Limited 8.49%
- GIC Private Limited 13.03%
- Hellman & Friedman Capital Partners X (Parallel), L.P. 16%
- Blackstone Holdings II L.P. 10.2%
- FMR LLC 5.5%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 4, 2026
- Regulation FD disclosure Oct 21, 2026
- Departure or appointment of directors or officers Oct 15, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.